Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 768-773

  Yilmaz, Ozge ^a   Karaman, Meral ^b   Bagriyanik, H Alper ^b   Firinci, Fatih ^b   Kiray, Muge ^b   Turkeli, Ahmet ^a   Karaman, Ozkan ^b   Yuksel, Hasan ^a  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Mouse model of asthma; Remodeling Inflammation; Steroid; Tumor necrosis factor

Indexed keywords

DEXAMETHASONE; ETANERCEPT; TUMOR NECROSIS FACTOR;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BASEMENT MEMBRANE; CELL ISOLATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ELECTRON MICROSCOPY; GOBLET CELL; HISTOPATHOLOGY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE; TREATMENT DURATION;

INFLAMMATION; MOUSE MODEL OF ASTHMA; REMODELING; STEROID; TUMOR NECROSIS FACTOR;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ASTHMA; CELL COUNT; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; GOBLET CELLS; IMMUNOGLOBULIN G; LUNG; MAST CELLS; MICE, INBRED BALB C; OVALBUMIN; RECEPTORS, TUMOR NECROSIS FACTOR; RESPIRATORY MUCOSA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884793076     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.08.021     Document Type: Article

References (28)

1. J.Y. Cho Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic Korean J Intern Med 26 2011 367 383
2. Y. Cai, Y.X. Cao, S.M. Lu, C.B. Xu, and L.O. Cardell Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats Int Immunol 23 2011 443 451
3. K.F. Chung Cytokines in chronic obstructive pulmonary disease Eur Respir J Suppl 34 2001 50s 59s (Pubitemid 34760609)
4. M.A. Berry, B. Hargadon, M. Shelley, D. Parker, D.E. Shaw, and R.H. Green Evidence of a role of tumor necrosis factor alpha in refractory asthma N Engl J Med 354 2006 697 708 (Pubitemid 43247140)
5. J.Y. Cho, A. Pham, P. Rosenthal, M. Miller, T. Doherty, and D.H. Broide Chronic OVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling Int Immunopharmacol 11 2011 1038 1044
6. S.T. Holgate, M. Noonan, P. Chanez, W. Busse, L. Dupont, and I. Pavord Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial Eur Respir J 37 2011 1352 1359
7. J. Temelovski, S.P. Hogan, D.P. Shepher, P.S. Foster, and R.K. Kumar An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen Thorax 53 1998 849 856 (Pubitemid 28459541)
8. F.N. Rouhani, C.A. Meitin, M. Kaler, D. Miskinis-Hilligoss, M. Stylianou, and S.J. Levine Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation Respir Med 99 2005 1175 1182 (Pubitemid 41102656)
9. C. Brightling, M. Berry, and Y. Amrani Targeting TNF-alpha: a novel therapeutic approach for asthma J Allergy Clin Immunol 121 2008 5 10
10. E.M. Erin, B.R. Leaker, G.C. Nicholson, A.J. Tan, L.M. Green, and H. Neighbour The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma Am J Respir Crit Care Med 174 2006 753 762 (Pubitemid 44511656)
11. J.B. Morjaria, A.J. Chauhan, K.S. Babu, R. Polosa, D.E. Davies, and S.T. Holgate The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: A double blind, randomised, placebo controlled trial Thorax 63 2008 584 591 (Pubitemid 351969250)
12. S.E. Wenzel, P.J. Barnes, E.R. Bleecker, J. Bousquet, W. Busse, and S.E. Dahlén A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma Am J Respir Crit Care Med 179 2009 549 558
13. S.R. Durrani, R.K. Viswanathan, and W.W. Busse What effect does asthma treatment have on airway remodeling? Current perspectives J Allergy Clin Immunol 128 2011 439 448
14. M. Baraket, B.G. Oliver, J.K. Burgess, S. Lim, G.G. King, and J.L. Black Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study Respir Res 13 2012 11
15. C. Ward, M. Pais, R. Bish, D. Reid, B. Feltis, and D. Johns Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax 57 2002 309 316 (Pubitemid 34298927)
16. M. Hoshino, Y. Nakamura, J.J. Sim, Y. Yamashiro, K. Uchida, and K. Hosaka Inhaledcorticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma Clin Exp Allergy 28 1998 568 577 (Pubitemid 28238271)
17. C. Bergeron, H.P. Hauber, M. Gotfried, K. Newman, R. Dhanda, and R.J. Servi Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide J Allergy Clin Immunol 116 2005 983 989 (Pubitemid 41571776)
18. F. Capraz, E. Kunter, H. Cermik, A. Ilvan, and S. Pocan The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics Lung 185 2007 89 96 (Pubitemid 46571878)
19. J.L. Lordan, F. Bucchieri, A. Richter, A. Konstantinidis, J.W. Holloway, and M. Thornber Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells J Immunol 169 2002 407 414 (Pubitemid 34686162)
20. F. Sabatini, M. Silvestri, R. Sale, L. Scarso, A.C. Defilippi, and F.M. Risso Fibroblast-eosinophil interaction: modulation of adhesion molecules expression and chemokine release by human fetal lung fibroblasts in response to IL-4 and TNF-alpha Immunol Lett 84 2002 173 178 (Pubitemid 35292376)
21. K. Goto, Y. Chiba, K. Matsusue, Y. Hattori, Y. Maitani, and H. Sakai The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells Pharmacol Res 61 2010 466 472
22. A.G. Guedes, J.A. Jude, J. Paulin, H. Kita, F.E. Lund, and M.S. Kannan Role of CD38 in TNF-alpha-induced airway hyperresponsiveness Am J Physiol Lung Cell Mol Physiol 294 2008 L290 L299
23. C.J. Koziol-White, and R.A. Panettieri Jr. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease Immunol Rev 242 2011 178 185
24. D. Jain, S. Keslacy, O. Tliba, Y. Cao, S. Kierstein, and K. Amin Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness Immunobiology 213 2008 499 509
25. O. Tliba, and Y. Amrani Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways Proc Am Thorac Soc 5 2008 106 112
26. S. Reuter, A. Heinz, M. Sieren, R. Wiewrodt, E.W. Gelfand, and M. Stassen Mast cell-derived tumour necrosis factor is essential for allergic airway disease Eur Respir J 31 2008 773 782
27. O.H. Chai, E.H. Han, H.K. Lee, and C.H. Song Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-α Exp Mol Med 43 2011 35 43
28. S. Boero, F. Sabatini, M. Silvestri, L. Petecchia, A. Nachira, and A. Pezzolo Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide Immunol Lett 112 2007 39 46 (Pubitemid 47331687)